At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
Any organisms that enter through needle puncture proliferate more slowly at refrigeration temperatures than at room temperature
In liver aging studies, the preparation reduced lipid peroxidation damage, improved detoxification function, inhibited liver fibrosis, and ameliorated aging-related pathological changes
Each batch is independently verified by Vanguard Laboratory, an ISO-certified facility that tests for identity, purity, quantity, and endotoxins
